MEDIFRON DBT INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in Republic of Korea, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are FLYNN DANIEL L, BIFTU TESFAYE and APOGLYX AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Biotechnology | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Special foods | |
#7 | Foods | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Lee Jeewoo | 10 |
#2 | Bahrenberg Gregor | 9 |
#3 | Christoph Thomas | 9 |
#4 | Damann Nils | 9 |
#5 | Lesch Bernhard | 9 |
#6 | Schiene Klaus | 9 |
#7 | Stockhausen Hannelore | 8 |
#8 | Frormann Sven | 7 |
#9 | Frank-Foltyn Robert | 6 |
#10 | Saunders Derek | 5 |
Publication | Filing date | Title |
---|---|---|
KR20200144180A | N-substituted thiourea or urea derivatives and pharmaceutical composition for use in preventing or treating glutaminyl cyclase activity related diseases containing the same as an active ingredient | |
KR20180112558A | Transgenic porcine model for alzheimer's disease and producing method thereof | |
KR20180062526A | Phenylthiourea derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating glutaminyl cyclase activity related diseases containing the same as an active ingredient |